AMR: Challenges and Insight w/ Alfonso Chang

The fight against Antimicrobial Resistance (AMR) is challenging due to financial, ethical, and legislative issues. Combating infectious disease can prove to be a risky financial investment but much less in comparison to the global impact if solutions are not researched. Alfonso Chang is the Managing Director of Relativity Healthcare Partners; he shares insight into the challenges and how to overcome them:- Investor Hesitancy- Higher clinical and ethical implications- Preference of existing therapies over new ones- Unintended consequences from lawmakers due to drafted legislative languageCheck out the resources below for more information:- Alfonso’s LinkedIn- Our host: John Stanford’s LinkedInTo hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.